Wirtualne życie

JohnyBotreiht · Gość

In March 2004, Eli Lilly (at the request of [link widoczny dla zalogowanych] the FDA) issued a warning statement describing the increased risk of hyperglycemia and diabetes in patients taking ZyprexaŽ. Eli Lilly said that some extreme cases of Hyperglycemia, resulting in coma and death, have been reported in patients treated with atypical antipsychotics, including ZyprexaŽ. Eli Lily referenced epidemiological [link widoczny dla zalogowanych] studies that suggest an increased risk of treatment-emergent hyperglycemia-related adverse events.